On March 28, the "2022 China Synthetic Biology Green Application and Industry Perception Research Report" (referred to as the "Report") was officially released by Phoenix Technology. It is the first industry report in China's synthetic biology field based on industry perception research.
"2022 China Synthetic Biology Green Application and Industry Perception Research Report"
The "Report" comprehensively reviews the current development of synthetic biology in China and conducts thousands of questionnaire surveys. It analyzes the technological and product layout of hundreds of companies and selects the top ten typical synthetic biology applications. Among them, Tidetron Bioworks, located in Guangzhou, Guangdong Province, was chosen for its breakthrough in the synthesis technology of small molecular peptides, which increased the production efficiency of individual peptides by about 40 times.
In recent years, With the vigorous development of synthetic biology technology, its advantages in the beauty industry have become increasingly prominent. In recent years compared to traditional chemical synthesis and biological fermentation methods, biocatalysis has played a significant role in breaking through raw material limitations and improving synthesis efficiency. It has remarkable advantages in cost reduction, efficiency improvement, and environmental friendliness. From animal-derived collagen to recombinant collagen, biocatalysis of squalene/squalane replaces the extraction of shark liver, and transdermal peptide technology provides more possibilities for effective skincare. Biocatalysis technology profoundly influences the beauty industry's technological innovation and industrial upgrading.
The application of biotechnology in the beauty industry has gradually become a new trend. Tidetron Bioworks relies on the Tidetron Altra strain library, component library, and peptide tag-directed evolution technology to achieve a breakthrough in the synthesis technology of small molecular peptides. It has shortened the synthesis cycle of individual peptides to 1-3 months, thereby improving production efficiency by about 40 times. Ultimately, it has developed synthesis pathways for nearly 20 small molecular peptides, and several exclusive patents have been applied for related achievements. The small molecular peptide synthesis system it has built has opened up new ideas for peptide biosynthesis and industrial applications in China.
(Image caption: Tidetron Bioworks researchers conducting experiments)